RACHEL PETRUS: Open Payments
NPI 1255821260 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 25 payments from 15 companies in 2025. Trend: 2023 $764 · 2024 $1,419 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $96 |
| E.R. Squibb & Sons, L.L.C. | 2 | $94 |
| Medtronic, Inc. | 2 | $86 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Boston Scientific Corporation | 1 | $75 |
| SCPHARMACEUTICALS INC. | 3 | $58 |
| BridgeBio Pharma, Inc. | 2 | $50 |
| PFIZER INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Mannkind Corporation | 1 | $23 |
Products named: REPATHA, SYMPLICITY G3, VERQUVO, WATCHMAN FLX, FUROSCIX, Attruby, VYNDAQEL, LEQVIO.
Industry payments across AZ — which companies pay providers there.
